INNV vs HCSG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
INNV · InnovAge Holding$9.16 ▲ 2.81%
HCSG · Healthcare Services Group$24.72 ▼ 0.20%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- INNV +72.2%
- HCSG +32.9%
Head to head
| Metric | INNV | HCSG |
|---|---|---|
| Price | $9.16 | $24.72 |
| Change today | ▲ 2.81% | ▼ 0.20% |
| Market cap | $1.25B | $1.67B |
| Return, 3 months | -16.9% | +8.4% |
| Return, year to date | +76.5% | +29.3% |
| Return, 1 year | +74.5% | +37.6% |
| P/E (TTM) | 152.7 | 16.7 |
| P/B | 4.9 | 3.1 |
| P/E percentile vs own 5y | 91st | 9th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +12.1% | +3.3% |
| Net profit growth (YoY) | +172.2% | -42.1% |
| Gross margin | 23.6% | 16.1% |
| Operating margin | 1.7% | 6.3% |
| Net margin | 0.9% | 5.6% |
| Return on equity | 3.6% | 20.4% |
| Analyst target vs. price | +31.0% | +2.5% |
| Analyst buy share | 33% | 33% |
| RSI (14) | 48 | 55 |
| 30-day volatility | 48.5% | 50.6% |
| Max drawdown, 1 year | -33.2% | -19.9% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- HCSG is the largest of the group by market value.
- INNV has returned the most over the past year.
- HCSG carries the lowest trailing P/E.
- INNV is growing revenue fastest.
- HCSG keeps the most profit per dollar of sales.
- INNV has been the calmest stock over the last 30 days.